---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-007049"
form_type: "8-K"
ticker: "SLS"
cik: "0001390478"
company_name: "SELLAS Life Sciences Group, Inc."
filed_at: "2025-01-29T23:59:59+00:00"
generated_at: "2026-05-27T06:39:24.183732+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# SELLAS Life Sciences raises $25M in registered direct offering of common stock and warrants

## Summary
- 19,685,040 shares (or pre-funded warrants) plus 19,685,040 common warrants at $1.27 combined price.
- Warrants exercisable at $1.20 per share, expire 5 years from issuance.
- Gross proceeds ~$25M; net proceeds for working capital and general corporate purposes.
- Offering priced at-the-market under Nasdaq rules; expected to close Jan 29, 2025.
- Single healthcare-focused institutional investor; A.G.P. and Maxim as placement agents.

## SEC filing metadata
- accession: 0001104659-25-007049
- form_type: 8-K
- ticker: SLS
- cik: 0001390478
- company_name: SELLAS Life Sciences Group, Inc.
- filed_at: 2025-01-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1390478/000110465925007049/0001104659-25-007049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1390478/000110465925007049/tm254790d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-007049
- JSON: https://secwatch.observer/filing/0001104659-25-007049.json
- Plain text: https://secwatch.observer/filing/0001104659-25-007049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.